347 related articles for article (PubMed ID: 18625775)
1. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775
[TBL] [Abstract][Full Text] [Related]
2. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
3. Role for cell density in antifungal drug resistance in Candida albicans biofilms.
Perumal P; Mekala S; Chaffin WL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2454-63. PubMed ID: 17502416
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department.
Touil HFZ; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2018 Sep; 28(3):414-418. PubMed ID: 30032993
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
[TBL] [Abstract][Full Text] [Related]
7. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA
Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Vediyappan G; Rossignol T; d'Enfert C
Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
[TBL] [Abstract][Full Text] [Related]
10. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
[TBL] [Abstract][Full Text] [Related]
12. Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.
Kulkarny VV; Chavez-Dozal A; Rane HS; Jahng M; Bernardo SM; Parra KJ; Lee SA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7501-9. PubMed ID: 25288082
[TBL] [Abstract][Full Text] [Related]
13. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
DiDone L; Oga D; Krysan DJ
Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
[TBL] [Abstract][Full Text] [Related]
14. Biofilm formation by and antifungal susceptibility of Candida isolates from urine.
Jain N; Kohli R; Cook E; Gialanella P; Chang T; Fries BC
Appl Environ Microbiol; 2007 Mar; 73(6):1697-703. PubMed ID: 17261524
[TBL] [Abstract][Full Text] [Related]
15. In vitro Antifungal Effects of Berberine Against
Xie Y; Liu X; Zhou P
Drug Des Devel Ther; 2020; 14():87-101. PubMed ID: 32021094
[TBL] [Abstract][Full Text] [Related]
16. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
De Brucker K; De Cremer K; Cammue BP; Thevissen K
Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
18. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.
Martins M; Henriques M; Lopez-Ribot JL; Oliveira R
Mycoses; 2012 Jan; 55(1):80-5. PubMed ID: 21668524
[TBL] [Abstract][Full Text] [Related]
19. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
20. Microplate Alamar blue assay for susceptibility testing of Candida albicans biofilms.
Repp KK; Menor SA; Pettit RK
Med Mycol; 2007 Nov; 45(7):603-7. PubMed ID: 17885957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
